Intravenous Gammaglobulin Replacement for Prophylaxis of Infection in Preterm Neonates

  • Gaetano Chirico
  • Giorgio Rondini
  • Alessandro Plebani
  • Alberto Chiara
  • Alberto G. Ugazio
Conference paper


Despite the improvements made in medical care in recent years, infection remains a major problem in newborn infants, because rapid diagnosis is difficult and therapy is not always effective (Eisenfeld et al. 1983). Preterm infants with gestational age ≤ 34 weeks and birth weight ≤ 1500 g are particularly at risk: the incidence of systemic infection in these infants, in fact, is about 32%, with a mortality rate of 11% (Usher 1981). The high susceptibility to infections is mainly due to the neonatal impairment of host defenses; both the aspecific and antigen-specific components of the immune system are deficient in the preterm neonate. The antibody deficiency is one of the most important contributory factors in the neonate’s high susceptibility to infections: levels of IgG, all acquired via transplacental passage from the mother, are, in fact, definitely low and often similar to those found in patients with congenital agammaglobulinemia. This is because the transplacental passage occurs almost exclusively during the last 6 weeks of gestation (Hobbs and Yeung 1968; Pilgrim et al. 1975).


Necrotizing Enterocolitis Preterm Neonate Control Infant Transplacental Passage Opsonic Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Amer J, Ott E, Ibbott FA, O’Brien D, Kempe H (1963) The effect of monthly gamma-globulin administration on morbidity and mortality from infection in premature infants during the first year of life. Pediatrics 32: 4–9.PubMedGoogle Scholar
  2. Boyer KM, Papierniak CK, Gadzala RN, Parvin JD, Gotoff SP (1984) Transplacental passage of IgG antibody to group B streptococcus serotype la. J Pediatr 104: 618–620.PubMedCrossRefGoogle Scholar
  3. Chirico G, Duse M, Chiara A, Rondini G, Ugazio AG (1983a) Neonatal immunodeficiency and new perspective of prophylaxis of infections with intravenous intact gammaglobulin. XVII International Congress of Pediatrics. Proceedings of symposia, vol 2, p 579.Google Scholar
  4. Chirico G, Marconi M, Colombo A, Chiara A, Rondini G, Ugazio AG (1983b) Deficiency of neutrophil phagocytosis in premature infants: effect of vitamin E supplementation. Acta Paediatr Scand 72: 521–524.PubMedCrossRefGoogle Scholar
  5. Chirico G, Marconi M, De Amici M, Gasparoni A, Mingrat G, Chiara A, Rondini G, Ugazio AG (1985) Deficiency of neutrophil bactericidal activity in term and preterm infants. A longitudinal study. Biol Neonate 47: 125–129.PubMedCrossRefGoogle Scholar
  6. Christensen KK, Christensen P, Bucher HV, Duc G, Kind CH, Mieth D, Müller B, Seger RA (1984) Intravenous administration of human IgG to newborn infants: changes in serum antibody levels to group B streptococci. Eur J Pediatr 143: 123–127.PubMedCrossRefGoogle Scholar
  7. Cooper MD, Gathings WE, Kubagawa H (1982) Immaturity of B lymphocytes in the newborn. Riv Ital Pediatr 8: 839–847.Google Scholar
  8. Corrigan JJ Jr (1981) Hematologic manifestation of congenital infections. Clin Perinatol 8: 499–507.PubMedGoogle Scholar
  9. Dubowitz LMS, Dubowitz W, Goldberg C (1970) Clinical assessment of gestational age in the newborn infant. J Pediatr 77: 1–10.PubMedCrossRefGoogle Scholar
  10. Dwyer JM (1984) Thirty years of supplying the missing link. History of gamma globulin therapy for immunodeficient states. Am J Med 76: 46–52.PubMedCrossRefGoogle Scholar
  11. Eisenfeld L, Ermocilla R, Wirtschafter D, Cassady G (1983) Systemic bacterial infections in neonatal deaths. Am J Dis Child 173: 645–649.Google Scholar
  12. Fischer GW, Weisman LB, Hemming VG, London W, Hunter KW, Bosworth JM, Sever JL, Wilson SR, Curfman BL (1984) Intravenous immunoglobulin in neonatal group B streptococcal disease. Am J Med 76: 117–123.PubMedCrossRefGoogle Scholar
  13. Forman ML, Stiehm R (1969) Impaired opsonic activity but normal phagocytosis in low-birth-weight infants. N Engl J Med 23: 926–931.CrossRefGoogle Scholar
  14. Hayward AR, Lydyard PM (1979) B cell function in the newborn. Pediatrics 64: 758–764.PubMedGoogle Scholar
  15. Hemming VG, Overall JC, Britt MR (1976) Nosocomial infections in a newborn intensive-care unit. Results of forty-one months of surveillance. N Engl J Med 10: 1310–1315.CrossRefGoogle Scholar
  16. Hill HR, Augustine NH, Shigeoka A (1984) Comparative opsonic activity of intravenous gamma globulin preparations for common bacterial pathogens. Am J Med 76: 61–66.PubMedCrossRefGoogle Scholar
  17. Hobbs JR, Yeung CY (1968) Serum G-globulin levels in normal, premature, post-mature, and “small-for-dates” newborn babies. Lancet 1: 1167–1170.PubMedGoogle Scholar
  18. Marks MI, Welch DF (1981) Diagnosis of bacterial infections of the newborn infant. Clin Perinatol 8: 537–558.PubMedGoogle Scholar
  19. Morell A, Schurch B, Ryser D, Hofer F, Skvaril F, Barandun S (1980) In vivo behaviour of gamma globulin preparations. Vox Sang 38: 272–283.PubMedCrossRefGoogle Scholar
  20. Notarangelo LD, Chirico G, Chiara A, Colombo A, Rondini G, Plebani A, Martini A, Ugazio AG (1984) Activity of classical and alternative pathways of complement in preterm and small for gestational age infants. Pediatr Res 18: 281–285.PubMedCrossRefGoogle Scholar
  21. Oxelius VA (1984) Immunoglobulin G (IgG) subclasses and human disease. Am J Med 76: 7–18.PubMedCrossRefGoogle Scholar
  22. Pilgrim U, Fontanellaz HP, Hitzig WH, Evers G (1975) Normal values of immunoglobulins in premature and in full-term infants, calculated as percentiles. Helv Paediat Acta 30: 121–134.PubMedGoogle Scholar
  23. Römer J, Morgenthaler JJ, Scherz R, Skvaril F (1982a) Characterization of various immunoglobulin preparations for intravenous application: I. Protein composition and antibody content. Vox Sang 42: 62–73.PubMedGoogle Scholar
  24. Römer J, Späth PJ, Skvaril F, Nydegger UE (1982b) Characterization of various immunoglobulin preparations for intravenous application: II. Complement activation and binding to Staphylococcus protein A. Vox Sang 42: 74–80.PubMedGoogle Scholar
  25. Sacchi F, Rondini G, Mingrat G, Stronati M, Gancia GP, Marseglia GL, Siccardi AG (1982) Different maturation of neutrophil Chemotaxis in term and preterm newborn infants. J Pediatr 101: 273–274.PubMedCrossRefGoogle Scholar
  26. Santulli TV, Schullinger JN, Heird WC, Gongaware RD, Wigger J, Barlow B, Blanc WA, Berdon WE (1975) Acute necrotizing enterocolitis in infancy: A review of 64 cases. Pediatrics 55: 376–381.PubMedGoogle Scholar
  27. Steen JA (1960) Gammaglobulin in preventing infections in prematures. Arch Pediatr 77: 291–296.Google Scholar
  28. Stiehm ER (1979) Standard and special human immune serum globulins as therapeutic agents. Pediatrics 63: 301–313.PubMedGoogle Scholar
  29. Usher RH (1981) The special problems of the premature infant. In: Avery GB (ed) Neonatology pathophysiology and management of the newborn. Lippincott, Philadelphia, p 255.Google Scholar
  30. Van Furth R, Leijh PCJ, Klein F (1984) Correlation between opsonic activity for various microorganisms and composition of gammaglobulin preparations for intravenous use. J Infect Dis 149: 511–517.PubMedCrossRefGoogle Scholar
  31. Von Muralt G, Sidiropoulos D (1981) Intravenous Ig substitution therapy in the treatment of septicemia in preterm neonates. In: Nydegger VE (ed) Immunohemotherapy. Academic, London, pp 313–324.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • Gaetano Chirico
    • 1
  • Giorgio Rondini
    • 1
  • Alessandro Plebani
    • 1
  • Alberto Chiara
    • 1
  • Alberto G. Ugazio
    • 2
  1. 1.Division of Neonatal Intensive Care, IRCCS Policlinico San Matteo, Department of PediatricsUniversity of PaviaPaviaItaly
  2. 2.University of BresciaItaly

Personalised recommendations